Prognostic value of the delta neutrophil index for predicting 28-day mortality in intensive care unit patients with candidemia
- 28 October 2026
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 64 (11)
Abstract
Candidemia is associated with substantial mortality in critically ill patients, and early identification of patients at increased risk of death remains challenging. The delta neutrophil index (DNI), an automated hematological parameter reflecting circulating immature granulocytes, has been proposed as a prognostic marker in sepsis, but its role in candidemia remains unclear. This retrospective study included adults who developed candidemia during intensive care unit hospitalization between January 1, 2020, and December 31, 2023; patients with neutropenia, haematological malignancy receiving ongoing chemotherapy, or granulocyte colony-stimulating factor therapy were excluded. Patients were classified as survivors or non-survivors according to 28-day all-cause mortality after blood culture collection. DNI, leukocyte count, C-reactive protein, and procalcitonin were evaluated 24 h before, at the time of, and 24 h after blood culture collection. Multivariable logistic regression identified factors independently associated with mortality, and receiver operating characteristic analysis assessed the prognostic performance of DNI. Among 246 patients, 132 survived and 114 died. Non-survivors had higher APACHE II scores and more frequent acute kidney injury. DNI and procalcitonin levels were significantly higher in non-survivors at all three time points. In the primary multivariable model, acute kidney injury, DNI at blood culture collection, and procalcitonin at blood culture collection were independently associated with mortality; the association of DNI was attenuated and no longer statistically significant after further adjustment for Candida species and antifungal therapy. DNI showed limited discrimination, with area under the curve values ranging from 0.608 to 0.625; the highest value was observed at blood culture collection (0.625), with a cutoff of 2.4, 43.0% sensitivity, and 82.6% specificity. DNI may aid mortality risk stratification in candidemia but should not be used as a standalone prognostic marker.Keywords
Funding Information
- Ankara Bilkent City Hospital (62/2024)
This publication has 23 references indexed in Scilit:
- Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapyIntensive Care Medicine, 2025
- Deep Learning for the Early Diagnosis of CandidemiaInfectious Diseases and Therapy, 2025
- Risk factors associated with short-term mortality in patients with candidemia and the predictive value of serum cytokine levelCytokine, 2024
- “A decade of candidaemia: A comprehensive analysis of prognosis and risk factors at a Belgian tertiary hospital”Diagnostic Microbiology and Infectious Disease, 2024
- Candidemia in critically ill COVID-19 patients: Risk factors and impact on mortalityHeliyon, 2024
- Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort studyThe Lancet Infectious Diseases, 2023
- The delta neutrophil index (DNI) as a prognostic marker for mortality in adults with sepsis: a systematic review and meta-analysisScientific Reports, 2018
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Epidemiology of candidemia in intensive care unitsInternational Journal of Antimicrobial Agents, 2008
- Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyClinical Infectious Diseases, 2006